Bile acids attenuate PKM2 pathway activation in proinflammatory microglia

Abstract Glycolysis is the metabolic pathway that converts glucose into pyruvate. Central nervous system (CNS) pathologies, such as spinal cord injury (SCI) and ischemia, are accompanied by an increase of the glycolytic pathway in the damaged areas as part of the inflammatory response. Pyruvate kina...

Full description

Bibliographic Details
Main Authors: Lorenzo Romero-Ramírez, Concepción García-Rama, Siyu Wu, Jörg Mey
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-05408-3
_version_ 1818300300648251392
author Lorenzo Romero-Ramírez
Concepción García-Rama
Siyu Wu
Jörg Mey
author_facet Lorenzo Romero-Ramírez
Concepción García-Rama
Siyu Wu
Jörg Mey
author_sort Lorenzo Romero-Ramírez
collection DOAJ
description Abstract Glycolysis is the metabolic pathway that converts glucose into pyruvate. Central nervous system (CNS) pathologies, such as spinal cord injury (SCI) and ischemia, are accompanied by an increase of the glycolytic pathway in the damaged areas as part of the inflammatory response. Pyruvate kinase is a key glycolytic enzyme that converts phosphoenolpyruvate and ADP to pyruvate and ATP. The protein has two isoforms, PKM1 and PKM2, originated from the same gene. As a homodimer, PKM2 loses the pyruvate kinase activity and acts as a transcription factor that regulates the expression of target genes involved in glycolysis and inflammation. After SCI, resident microglia and hematogenous macrophages are key inducers of the inflammatory response with deleterious effects. Activation of the bile acid receptor TGR5 inhibits the pro-inflammatory NFκB pathway in microglia and macrophages. In the present study we have investigated whether bile acids affect the expression of glycolytic enzymes and their regulation by PKM2. Bacterial lipopolysaccharide (LPS) induced the expression of PKM1, PKM2 and its target genes in primary cultures of microglial and Raw264.7 macrophage cells. SCI caused an increase of PKM2 immunoreactivity in macrophages after SCI. Pretreatment with tauroursodeoxycholic acid (TUDCA) or taurolithocholic acid (TLCA) reduced the expression of PKM2 and its target genes in cell cultures. Similarly, after SCI, TUDCA treatment reduced the expression of PKM2 in the lesion center. These results confirm the importance of PKM2 in the inflammatory response in CNS pathologies and indicate a new mechanism of bile acids as regulators of PKM2 pathway.
first_indexed 2024-12-13T05:04:56Z
format Article
id doaj.art-4eb333749cc746d59a9d3ae02b3eed42
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-13T05:04:56Z
publishDate 2022-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-4eb333749cc746d59a9d3ae02b3eed422022-12-21T23:58:42ZengNature PortfolioScientific Reports2045-23222022-01-0112111310.1038/s41598-022-05408-3Bile acids attenuate PKM2 pathway activation in proinflammatory microgliaLorenzo Romero-Ramírez0Concepción García-Rama1Siyu Wu2Jörg Mey3Laboratorio de Regeneración Nerviosa e Inmunidad Innata, Hospital Nacional de Parapléjicos, SESCAMLaboratorio de Regeneración Nerviosa e Inmunidad Innata, Hospital Nacional de Parapléjicos, SESCAMLaboratorio de Regeneración Nerviosa e Inmunidad Innata, Hospital Nacional de Parapléjicos, SESCAMLaboratorio de Regeneración Nerviosa e Inmunidad Innata, Hospital Nacional de Parapléjicos, SESCAMAbstract Glycolysis is the metabolic pathway that converts glucose into pyruvate. Central nervous system (CNS) pathologies, such as spinal cord injury (SCI) and ischemia, are accompanied by an increase of the glycolytic pathway in the damaged areas as part of the inflammatory response. Pyruvate kinase is a key glycolytic enzyme that converts phosphoenolpyruvate and ADP to pyruvate and ATP. The protein has two isoforms, PKM1 and PKM2, originated from the same gene. As a homodimer, PKM2 loses the pyruvate kinase activity and acts as a transcription factor that regulates the expression of target genes involved in glycolysis and inflammation. After SCI, resident microglia and hematogenous macrophages are key inducers of the inflammatory response with deleterious effects. Activation of the bile acid receptor TGR5 inhibits the pro-inflammatory NFκB pathway in microglia and macrophages. In the present study we have investigated whether bile acids affect the expression of glycolytic enzymes and their regulation by PKM2. Bacterial lipopolysaccharide (LPS) induced the expression of PKM1, PKM2 and its target genes in primary cultures of microglial and Raw264.7 macrophage cells. SCI caused an increase of PKM2 immunoreactivity in macrophages after SCI. Pretreatment with tauroursodeoxycholic acid (TUDCA) or taurolithocholic acid (TLCA) reduced the expression of PKM2 and its target genes in cell cultures. Similarly, after SCI, TUDCA treatment reduced the expression of PKM2 in the lesion center. These results confirm the importance of PKM2 in the inflammatory response in CNS pathologies and indicate a new mechanism of bile acids as regulators of PKM2 pathway.https://doi.org/10.1038/s41598-022-05408-3
spellingShingle Lorenzo Romero-Ramírez
Concepción García-Rama
Siyu Wu
Jörg Mey
Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
Scientific Reports
title Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
title_full Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
title_fullStr Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
title_full_unstemmed Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
title_short Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
title_sort bile acids attenuate pkm2 pathway activation in proinflammatory microglia
url https://doi.org/10.1038/s41598-022-05408-3
work_keys_str_mv AT lorenzoromeroramirez bileacidsattenuatepkm2pathwayactivationinproinflammatorymicroglia
AT concepciongarciarama bileacidsattenuatepkm2pathwayactivationinproinflammatorymicroglia
AT siyuwu bileacidsattenuatepkm2pathwayactivationinproinflammatorymicroglia
AT jorgmey bileacidsattenuatepkm2pathwayactivationinproinflammatorymicroglia